3 years ago

B24N24 fullerene as a carrier for 5-fluorouracil anti-cancer drug delivery: DFT studies

B24N24 fullerene as a carrier for 5-fluorouracil anti-cancer drug delivery: DFT studies
It has been previously indicated that BN nanostructures may be nontoxic and biocompatible. Here the potential application of a B24N24 is explored as a drug delivery system for anti-cancer 5-fluorouracil based on the density functional theory. This drug prefers to attach via its oxygen atoms to the B atoms of the cluster with adsorption energy about −11.90kcalmol−1 based on the dispersion corrected B3LYP level of theory. To make the cluster more appropriate for drug delivery, we replaced a B atom by Si or Al atom to improve the interaction strength. The calculated adsorption energies are about −50.13 and −34.19kcalmol−1 for Al and Si doped BN clusters, respectively. It was found that, in addition to the more negative adsorption energy, the electronic properties of Al-doped BN are significantly sensitive to the drug adsorption. Also, a drug release mechanism is proposed, indicating that in the low pH of the cancer cells the drug and BN cluster are considerably protonated, thereby separating the drug from the surface of the cluster.

Publisher URL: www.sciencedirect.com/science

DOI: S1093326317304060

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.